Rapport Therapeutics
RAPP
#4955
Rank
NZ$3.39 B
Marketcap
NZ$71.08
Share price
-2.89%
Change (1 day)
180.60%
Change (1 year)

Revenue for Rapport Therapeutics (RAPP)

Revenue in 2026 (TTM): NZ$34.74 Million

According to Rapport Therapeutics's latest financial reports the company's current revenue (TTM ) is NZ$34.39 Million. In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Rapport Therapeutics from 2023 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) NZ$34.74 M
2025 N/A
2024 N/A
2023 N/A